Global Gastrointestinal Cancer Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 127

Published Date: 05 Jan 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Gastrointestinal Cancer Treatment market size was valued at USD 4128.1 million in 2023 and is forecast to a readjusted size of USD 9137.4 million by 2030 with a CAGR of 12.0% during review period.

Gastrointestinal cancer is the abnormal condition of the gastrointestinal tract and associated organs of digestive system, which comprises esophagus, stomach, pancreas, biliary system, small intestine, large intestine, rectum, and anus. The symptoms of gastrointestinal cancer depend on the affected organ, and include obstruction (resulting in difficulty to swallow or excrete), unusual bleeding, or other related problems. This report focus on Gastrointestinal Cancer Treatment market.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Gastrointestinal Cancer Treatment industry chain, the market status of Hospitals (Surgery, Targeted Drugs Therapy), Clinics (Surgery, Targeted Drugs Therapy), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Gastrointestinal Cancer Treatment.

Regionally, the report analyzes the Gastrointestinal Cancer Treatment markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Gastrointestinal Cancer Treatment market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Gastrointestinal Cancer Treatment market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Gastrointestinal Cancer Treatment industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Surgery, Targeted Drugs Therapy).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Gastrointestinal Cancer Treatment market.

Regional Analysis: The report involves examining the Gastrointestinal Cancer Treatment market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Gastrointestinal Cancer Treatment market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Gastrointestinal Cancer Treatment:
Company Analysis: Report covers individual Gastrointestinal Cancer Treatment players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Gastrointestinal Cancer Treatment This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinics).

Technology Analysis: Report covers specific technologies relevant to Gastrointestinal Cancer Treatment. It assesses the current state, advancements, and potential future developments in Gastrointestinal Cancer Treatment areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Gastrointestinal Cancer Treatment market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Gastrointestinal Cancer Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
Surgery
Targeted Drugs Therapy
Chemo Therapy
Adjuvant Chemotherapy
Radiation Therapy

Market segment by Application
Hospitals
Clinics
Research Centers
Others

Market segment by players, this report covers
Eli Lilly
F. Hoffmann
GlaxoSmithKline
Merck
Novartis AG
Otsuka Holdings
Stryker Corporation
Boston Scientific Corporation
Johnson and Johnson
CONMED Corporation
Bristol-Myers Squibb
Pfizer
Celltrion Inc
Amgen Limited
Celgene Corporation
Sanofi
Mylan N.V.
Samsung Bioepis
Teva Pharmaceutical Industries Ltd.

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Gastrointestinal Cancer Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gastrointestinal Cancer Treatment, with revenue, gross margin and global market share of Gastrointestinal Cancer Treatment from 2019 to 2024.
Chapter 3, the Gastrointestinal Cancer Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Gastrointestinal Cancer Treatment market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gastrointestinal Cancer Treatment.
Chapter 13, to describe Gastrointestinal Cancer Treatment research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Gastrointestinal Cancer Treatment
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Gastrointestinal Cancer Treatment by Type
        1.3.1 Overview: Global Gastrointestinal Cancer Treatment Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Gastrointestinal Cancer Treatment Consumption Value Market Share by Type in 2023
        1.3.3 Surgery
        1.3.4 Targeted Drugs Therapy
        1.3.5 Chemo Therapy
        1.3.6 Adjuvant Chemotherapy
        1.3.7 Radiation Therapy
    1.4 Global Gastrointestinal Cancer Treatment Market by Application
        1.4.1 Overview: Global Gastrointestinal Cancer Treatment Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hospitals
        1.4.3 Clinics
        1.4.4 Research Centers
        1.4.5 Others
    1.5 Global Gastrointestinal Cancer Treatment Market Size & Forecast
    1.6 Global Gastrointestinal Cancer Treatment Market Size and Forecast by Region
        1.6.1 Global Gastrointestinal Cancer Treatment Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Gastrointestinal Cancer Treatment Market Size by Region, (2019-2030)
        1.6.3 North America Gastrointestinal Cancer Treatment Market Size and Prospect (2019-2030)
        1.6.4 Europe Gastrointestinal Cancer Treatment Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Gastrointestinal Cancer Treatment Market Size and Prospect (2019-2030)
        1.6.6 South America Gastrointestinal Cancer Treatment Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Gastrointestinal Cancer Treatment Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Eli Lilly
        2.1.1 Eli Lilly Details
        2.1.2 Eli Lilly Major Business
        2.1.3 Eli Lilly Gastrointestinal Cancer Treatment Product and Solutions
        2.1.4 Eli Lilly Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Eli Lilly Recent Developments and Future Plans
    2.2 F. Hoffmann
        2.2.1 F. Hoffmann Details
        2.2.2 F. Hoffmann Major Business
        2.2.3 F. Hoffmann Gastrointestinal Cancer Treatment Product and Solutions
        2.2.4 F. Hoffmann Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 F. Hoffmann Recent Developments and Future Plans
    2.3 GlaxoSmithKline
        2.3.1 GlaxoSmithKline Details
        2.3.2 GlaxoSmithKline Major Business
        2.3.3 GlaxoSmithKline Gastrointestinal Cancer Treatment Product and Solutions
        2.3.4 GlaxoSmithKline Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 GlaxoSmithKline Recent Developments and Future Plans
    2.4 Merck
        2.4.1 Merck Details
        2.4.2 Merck Major Business
        2.4.3 Merck Gastrointestinal Cancer Treatment Product and Solutions
        2.4.4 Merck Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Merck Recent Developments and Future Plans
    2.5 Novartis AG
        2.5.1 Novartis AG Details
        2.5.2 Novartis AG Major Business
        2.5.3 Novartis AG Gastrointestinal Cancer Treatment Product and Solutions
        2.5.4 Novartis AG Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Novartis AG Recent Developments and Future Plans
    2.6 Otsuka Holdings
        2.6.1 Otsuka Holdings Details
        2.6.2 Otsuka Holdings Major Business
        2.6.3 Otsuka Holdings Gastrointestinal Cancer Treatment Product and Solutions
        2.6.4 Otsuka Holdings Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Otsuka Holdings Recent Developments and Future Plans
    2.7 Stryker Corporation
        2.7.1 Stryker Corporation Details
        2.7.2 Stryker Corporation Major Business
        2.7.3 Stryker Corporation Gastrointestinal Cancer Treatment Product and Solutions
        2.7.4 Stryker Corporation Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Stryker Corporation Recent Developments and Future Plans
    2.8 Boston Scientific Corporation
        2.8.1 Boston Scientific Corporation Details
        2.8.2 Boston Scientific Corporation Major Business
        2.8.3 Boston Scientific Corporation Gastrointestinal Cancer Treatment Product and Solutions
        2.8.4 Boston Scientific Corporation Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Boston Scientific Corporation Recent Developments and Future Plans
    2.9 Johnson and Johnson
        2.9.1 Johnson and Johnson Details
        2.9.2 Johnson and Johnson Major Business
        2.9.3 Johnson and Johnson Gastrointestinal Cancer Treatment Product and Solutions
        2.9.4 Johnson and Johnson Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Johnson and Johnson Recent Developments and Future Plans
    2.10 CONMED Corporation
        2.10.1 CONMED Corporation Details
        2.10.2 CONMED Corporation Major Business
        2.10.3 CONMED Corporation Gastrointestinal Cancer Treatment Product and Solutions
        2.10.4 CONMED Corporation Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 CONMED Corporation Recent Developments and Future Plans
    2.11 Bristol-Myers Squibb
        2.11.1 Bristol-Myers Squibb Details
        2.11.2 Bristol-Myers Squibb Major Business
        2.11.3 Bristol-Myers Squibb Gastrointestinal Cancer Treatment Product and Solutions
        2.11.4 Bristol-Myers Squibb Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 Bristol-Myers Squibb Recent Developments and Future Plans
    2.12 Pfizer
        2.12.1 Pfizer Details
        2.12.2 Pfizer Major Business
        2.12.3 Pfizer Gastrointestinal Cancer Treatment Product and Solutions
        2.12.4 Pfizer Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 Pfizer Recent Developments and Future Plans
    2.13 Celltrion Inc
        2.13.1 Celltrion Inc Details
        2.13.2 Celltrion Inc Major Business
        2.13.3 Celltrion Inc Gastrointestinal Cancer Treatment Product and Solutions
        2.13.4 Celltrion Inc Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 Celltrion Inc Recent Developments and Future Plans
    2.14 Amgen Limited
        2.14.1 Amgen Limited Details
        2.14.2 Amgen Limited Major Business
        2.14.3 Amgen Limited Gastrointestinal Cancer Treatment Product and Solutions
        2.14.4 Amgen Limited Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.14.5 Amgen Limited Recent Developments and Future Plans
    2.15 Celgene Corporation
        2.15.1 Celgene Corporation Details
        2.15.2 Celgene Corporation Major Business
        2.15.3 Celgene Corporation Gastrointestinal Cancer Treatment Product and Solutions
        2.15.4 Celgene Corporation Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.15.5 Celgene Corporation Recent Developments and Future Plans
    2.16 Sanofi
        2.16.1 Sanofi Details
        2.16.2 Sanofi Major Business
        2.16.3 Sanofi Gastrointestinal Cancer Treatment Product and Solutions
        2.16.4 Sanofi Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.16.5 Sanofi Recent Developments and Future Plans
    2.17 Mylan N.V.
        2.17.1 Mylan N.V. Details
        2.17.2 Mylan N.V. Major Business
        2.17.3 Mylan N.V. Gastrointestinal Cancer Treatment Product and Solutions
        2.17.4 Mylan N.V. Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.17.5 Mylan N.V. Recent Developments and Future Plans
    2.18 Samsung Bioepis
        2.18.1 Samsung Bioepis Details
        2.18.2 Samsung Bioepis Major Business
        2.18.3 Samsung Bioepis Gastrointestinal Cancer Treatment Product and Solutions
        2.18.4 Samsung Bioepis Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.18.5 Samsung Bioepis Recent Developments and Future Plans
    2.19 Teva Pharmaceutical Industries Ltd.
        2.19.1 Teva Pharmaceutical Industries Ltd. Details
        2.19.2 Teva Pharmaceutical Industries Ltd. Major Business
        2.19.3 Teva Pharmaceutical Industries Ltd. Gastrointestinal Cancer Treatment Product and Solutions
        2.19.4 Teva Pharmaceutical Industries Ltd. Gastrointestinal Cancer Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.19.5 Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Gastrointestinal Cancer Treatment Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Gastrointestinal Cancer Treatment by Company Revenue
        3.2.2 Top 3 Gastrointestinal Cancer Treatment Players Market Share in 2023
        3.2.3 Top 6 Gastrointestinal Cancer Treatment Players Market Share in 2023
    3.3 Gastrointestinal Cancer Treatment Market: Overall Company Footprint Analysis
        3.3.1 Gastrointestinal Cancer Treatment Market: Region Footprint
        3.3.2 Gastrointestinal Cancer Treatment Market: Company Product Type Footprint
        3.3.3 Gastrointestinal Cancer Treatment Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Gastrointestinal Cancer Treatment Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Gastrointestinal Cancer Treatment Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Gastrointestinal Cancer Treatment Consumption Value Market Share by Application (2019-2024)
    5.2 Global Gastrointestinal Cancer Treatment Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Gastrointestinal Cancer Treatment Consumption Value by Type (2019-2030)
    6.2 North America Gastrointestinal Cancer Treatment Consumption Value by Application (2019-2030)
    6.3 North America Gastrointestinal Cancer Treatment Market Size by Country
        6.3.1 North America Gastrointestinal Cancer Treatment Consumption Value by Country (2019-2030)
        6.3.2 United States Gastrointestinal Cancer Treatment Market Size and Forecast (2019-2030)
        6.3.3 Canada Gastrointestinal Cancer Treatment Market Size and Forecast (2019-2030)
        6.3.4 Mexico Gastrointestinal Cancer Treatment Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Gastrointestinal Cancer Treatment Consumption Value by Type (2019-2030)
    7.2 Europe Gastrointestinal Cancer Treatment Consumption Value by Application (2019-2030)
    7.3 Europe Gastrointestinal Cancer Treatment Market Size by Country
        7.3.1 Europe Gastrointestinal Cancer Treatment Consumption Value by Country (2019-2030)
        7.3.2 Germany Gastrointestinal Cancer Treatment Market Size and Forecast (2019-2030)
        7.3.3 France Gastrointestinal Cancer Treatment Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Gastrointestinal Cancer Treatment Market Size and Forecast (2019-2030)
        7.3.5 Russia Gastrointestinal Cancer Treatment Market Size and Forecast (2019-2030)
        7.3.6 Italy Gastrointestinal Cancer Treatment Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Gastrointestinal Cancer Treatment Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Gastrointestinal Cancer Treatment Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Gastrointestinal Cancer Treatment Market Size by Region
        8.3.1 Asia-Pacific Gastrointestinal Cancer Treatment Consumption Value by Region (2019-2030)
        8.3.2 China Gastrointestinal Cancer Treatment Market Size and Forecast (2019-2030)
        8.3.3 Japan Gastrointestinal Cancer Treatment Market Size and Forecast (2019-2030)
        8.3.4 South Korea Gastrointestinal Cancer Treatment Market Size and Forecast (2019-2030)
        8.3.5 India Gastrointestinal Cancer Treatment Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Gastrointestinal Cancer Treatment Market Size and Forecast (2019-2030)
        8.3.7 Australia Gastrointestinal Cancer Treatment Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Gastrointestinal Cancer Treatment Consumption Value by Type (2019-2030)
    9.2 South America Gastrointestinal Cancer Treatment Consumption Value by Application (2019-2030)
    9.3 South America Gastrointestinal Cancer Treatment Market Size by Country
        9.3.1 South America Gastrointestinal Cancer Treatment Consumption Value by Country (2019-2030)
        9.3.2 Brazil Gastrointestinal Cancer Treatment Market Size and Forecast (2019-2030)
        9.3.3 Argentina Gastrointestinal Cancer Treatment Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Gastrointestinal Cancer Treatment Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Gastrointestinal Cancer Treatment Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Gastrointestinal Cancer Treatment Market Size by Country
        10.3.1 Middle East & Africa Gastrointestinal Cancer Treatment Consumption Value by Country (2019-2030)
        10.3.2 Turkey Gastrointestinal Cancer Treatment Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Gastrointestinal Cancer Treatment Market Size and Forecast (2019-2030)
        10.3.4 UAE Gastrointestinal Cancer Treatment Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Gastrointestinal Cancer Treatment Market Drivers
    11.2 Gastrointestinal Cancer Treatment Market Restraints
    11.3 Gastrointestinal Cancer Treatment Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Gastrointestinal Cancer Treatment Industry Chain
    12.2 Gastrointestinal Cancer Treatment Upstream Analysis
    12.3 Gastrointestinal Cancer Treatment Midstream Analysis
    12.4 Gastrointestinal Cancer Treatment Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Gastrointestinal Cancer Treatment Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Gastrointestinal Cancer Treatment Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Gastrointestinal Cancer Treatment Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Gastrointestinal Cancer Treatment Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. Eli Lilly Company Information, Head Office, and Major Competitors
    Table 6. Eli Lilly Major Business
    Table 7. Eli Lilly Gastrointestinal Cancer Treatment Product and Solutions
    Table 8. Eli Lilly Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. Eli Lilly Recent Developments and Future Plans
    Table 10. F. Hoffmann Company Information, Head Office, and Major Competitors
    Table 11. F. Hoffmann Major Business
    Table 12. F. Hoffmann Gastrointestinal Cancer Treatment Product and Solutions
    Table 13. F. Hoffmann Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. F. Hoffmann Recent Developments and Future Plans
    Table 15. GlaxoSmithKline Company Information, Head Office, and Major Competitors
    Table 16. GlaxoSmithKline Major Business
    Table 17. GlaxoSmithKline Gastrointestinal Cancer Treatment Product and Solutions
    Table 18. GlaxoSmithKline Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. GlaxoSmithKline Recent Developments and Future Plans
    Table 20. Merck Company Information, Head Office, and Major Competitors
    Table 21. Merck Major Business
    Table 22. Merck Gastrointestinal Cancer Treatment Product and Solutions
    Table 23. Merck Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. Merck Recent Developments and Future Plans
    Table 25. Novartis AG Company Information, Head Office, and Major Competitors
    Table 26. Novartis AG Major Business
    Table 27. Novartis AG Gastrointestinal Cancer Treatment Product and Solutions
    Table 28. Novartis AG Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. Novartis AG Recent Developments and Future Plans
    Table 30. Otsuka Holdings Company Information, Head Office, and Major Competitors
    Table 31. Otsuka Holdings Major Business
    Table 32. Otsuka Holdings Gastrointestinal Cancer Treatment Product and Solutions
    Table 33. Otsuka Holdings Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. Otsuka Holdings Recent Developments and Future Plans
    Table 35. Stryker Corporation Company Information, Head Office, and Major Competitors
    Table 36. Stryker Corporation Major Business
    Table 37. Stryker Corporation Gastrointestinal Cancer Treatment Product and Solutions
    Table 38. Stryker Corporation Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 39. Stryker Corporation Recent Developments and Future Plans
    Table 40. Boston Scientific Corporation Company Information, Head Office, and Major Competitors
    Table 41. Boston Scientific Corporation Major Business
    Table 42. Boston Scientific Corporation Gastrointestinal Cancer Treatment Product and Solutions
    Table 43. Boston Scientific Corporation Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 44. Boston Scientific Corporation Recent Developments and Future Plans
    Table 45. Johnson and Johnson Company Information, Head Office, and Major Competitors
    Table 46. Johnson and Johnson Major Business
    Table 47. Johnson and Johnson Gastrointestinal Cancer Treatment Product and Solutions
    Table 48. Johnson and Johnson Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 49. Johnson and Johnson Recent Developments and Future Plans
    Table 50. CONMED Corporation Company Information, Head Office, and Major Competitors
    Table 51. CONMED Corporation Major Business
    Table 52. CONMED Corporation Gastrointestinal Cancer Treatment Product and Solutions
    Table 53. CONMED Corporation Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 54. CONMED Corporation Recent Developments and Future Plans
    Table 55. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
    Table 56. Bristol-Myers Squibb Major Business
    Table 57. Bristol-Myers Squibb Gastrointestinal Cancer Treatment Product and Solutions
    Table 58. Bristol-Myers Squibb Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 59. Bristol-Myers Squibb Recent Developments and Future Plans
    Table 60. Pfizer Company Information, Head Office, and Major Competitors
    Table 61. Pfizer Major Business
    Table 62. Pfizer Gastrointestinal Cancer Treatment Product and Solutions
    Table 63. Pfizer Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 64. Pfizer Recent Developments and Future Plans
    Table 65. Celltrion Inc Company Information, Head Office, and Major Competitors
    Table 66. Celltrion Inc Major Business
    Table 67. Celltrion Inc Gastrointestinal Cancer Treatment Product and Solutions
    Table 68. Celltrion Inc Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 69. Celltrion Inc Recent Developments and Future Plans
    Table 70. Amgen Limited Company Information, Head Office, and Major Competitors
    Table 71. Amgen Limited Major Business
    Table 72. Amgen Limited Gastrointestinal Cancer Treatment Product and Solutions
    Table 73. Amgen Limited Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 74. Amgen Limited Recent Developments and Future Plans
    Table 75. Celgene Corporation Company Information, Head Office, and Major Competitors
    Table 76. Celgene Corporation Major Business
    Table 77. Celgene Corporation Gastrointestinal Cancer Treatment Product and Solutions
    Table 78. Celgene Corporation Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 79. Celgene Corporation Recent Developments and Future Plans
    Table 80. Sanofi Company Information, Head Office, and Major Competitors
    Table 81. Sanofi Major Business
    Table 82. Sanofi Gastrointestinal Cancer Treatment Product and Solutions
    Table 83. Sanofi Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 84. Sanofi Recent Developments and Future Plans
    Table 85. Mylan N.V. Company Information, Head Office, and Major Competitors
    Table 86. Mylan N.V. Major Business
    Table 87. Mylan N.V. Gastrointestinal Cancer Treatment Product and Solutions
    Table 88. Mylan N.V. Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 89. Mylan N.V. Recent Developments and Future Plans
    Table 90. Samsung Bioepis Company Information, Head Office, and Major Competitors
    Table 91. Samsung Bioepis Major Business
    Table 92. Samsung Bioepis Gastrointestinal Cancer Treatment Product and Solutions
    Table 93. Samsung Bioepis Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 94. Samsung Bioepis Recent Developments and Future Plans
    Table 95. Teva Pharmaceutical Industries Ltd. Company Information, Head Office, and Major Competitors
    Table 96. Teva Pharmaceutical Industries Ltd. Major Business
    Table 97. Teva Pharmaceutical Industries Ltd. Gastrointestinal Cancer Treatment Product and Solutions
    Table 98. Teva Pharmaceutical Industries Ltd. Gastrointestinal Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 99. Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans
    Table 100. Global Gastrointestinal Cancer Treatment Revenue (USD Million) by Players (2019-2024)
    Table 101. Global Gastrointestinal Cancer Treatment Revenue Share by Players (2019-2024)
    Table 102. Breakdown of Gastrointestinal Cancer Treatment by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 103. Market Position of Players in Gastrointestinal Cancer Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 104. Head Office of Key Gastrointestinal Cancer Treatment Players
    Table 105. Gastrointestinal Cancer Treatment Market: Company Product Type Footprint
    Table 106. Gastrointestinal Cancer Treatment Market: Company Product Application Footprint
    Table 107. Gastrointestinal Cancer Treatment New Market Entrants and Barriers to Market Entry
    Table 108. Gastrointestinal Cancer Treatment Mergers, Acquisition, Agreements, and Collaborations
    Table 109. Global Gastrointestinal Cancer Treatment Consumption Value (USD Million) by Type (2019-2024)
    Table 110. Global Gastrointestinal Cancer Treatment Consumption Value Share by Type (2019-2024)
    Table 111. Global Gastrointestinal Cancer Treatment Consumption Value Forecast by Type (2025-2030)
    Table 112. Global Gastrointestinal Cancer Treatment Consumption Value by Application (2019-2024)
    Table 113. Global Gastrointestinal Cancer Treatment Consumption Value Forecast by Application (2025-2030)
    Table 114. North America Gastrointestinal Cancer Treatment Consumption Value by Type (2019-2024) & (USD Million)
    Table 115. North America Gastrointestinal Cancer Treatment Consumption Value by Type (2025-2030) & (USD Million)
    Table 116. North America Gastrointestinal Cancer Treatment Consumption Value by Application (2019-2024) & (USD Million)
    Table 117. North America Gastrointestinal Cancer Treatment Consumption Value by Application (2025-2030) & (USD Million)
    Table 118. North America Gastrointestinal Cancer Treatment Consumption Value by Country (2019-2024) & (USD Million)
    Table 119. North America Gastrointestinal Cancer Treatment Consumption Value by Country (2025-2030) & (USD Million)
    Table 120. Europe Gastrointestinal Cancer Treatment Consumption Value by Type (2019-2024) & (USD Million)
    Table 121. Europe Gastrointestinal Cancer Treatment Consumption Value by Type (2025-2030) & (USD Million)
    Table 122. Europe Gastrointestinal Cancer Treatment Consumption Value by Application (2019-2024) & (USD Million)
    Table 123. Europe Gastrointestinal Cancer Treatment Consumption Value by Application (2025-2030) & (USD Million)
    Table 124. Europe Gastrointestinal Cancer Treatment Consumption Value by Country (2019-2024) & (USD Million)
    Table 125. Europe Gastrointestinal Cancer Treatment Consumption Value by Country (2025-2030) & (USD Million)
    Table 126. Asia-Pacific Gastrointestinal Cancer Treatment Consumption Value by Type (2019-2024) & (USD Million)
    Table 127. Asia-Pacific Gastrointestinal Cancer Treatment Consumption Value by Type (2025-2030) & (USD Million)
    Table 128. Asia-Pacific Gastrointestinal Cancer Treatment Consumption Value by Application (2019-2024) & (USD Million)
    Table 129. Asia-Pacific Gastrointestinal Cancer Treatment Consumption Value by Application (2025-2030) & (USD Million)
    Table 130. Asia-Pacific Gastrointestinal Cancer Treatment Consumption Value by Region (2019-2024) & (USD Million)
    Table 131. Asia-Pacific Gastrointestinal Cancer Treatment Consumption Value by Region (2025-2030) & (USD Million)
    Table 132. South America Gastrointestinal Cancer Treatment Consumption Value by Type (2019-2024) & (USD Million)
    Table 133. South America Gastrointestinal Cancer Treatment Consumption Value by Type (2025-2030) & (USD Million)
    Table 134. South America Gastrointestinal Cancer Treatment Consumption Value by Application (2019-2024) & (USD Million)
    Table 135. South America Gastrointestinal Cancer Treatment Consumption Value by Application (2025-2030) & (USD Million)
    Table 136. South America Gastrointestinal Cancer Treatment Consumption Value by Country (2019-2024) & (USD Million)
    Table 137. South America Gastrointestinal Cancer Treatment Consumption Value by Country (2025-2030) & (USD Million)
    Table 138. Middle East & Africa Gastrointestinal Cancer Treatment Consumption Value by Type (2019-2024) & (USD Million)
    Table 139. Middle East & Africa Gastrointestinal Cancer Treatment Consumption Value by Type (2025-2030) & (USD Million)
    Table 140. Middle East & Africa Gastrointestinal Cancer Treatment Consumption Value by Application (2019-2024) & (USD Million)
    Table 141. Middle East & Africa Gastrointestinal Cancer Treatment Consumption Value by Application (2025-2030) & (USD Million)
    Table 142. Middle East & Africa Gastrointestinal Cancer Treatment Consumption Value by Country (2019-2024) & (USD Million)
    Table 143. Middle East & Africa Gastrointestinal Cancer Treatment Consumption Value by Country (2025-2030) & (USD Million)
    Table 144. Gastrointestinal Cancer Treatment Raw Material
    Table 145. Key Suppliers of Gastrointestinal Cancer Treatment Raw Materials
List of Figures
    Figure 1. Gastrointestinal Cancer Treatment Picture
    Figure 2. Global Gastrointestinal Cancer Treatment Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Gastrointestinal Cancer Treatment Consumption Value Market Share by Type in 2023
    Figure 4. Surgery
    Figure 5. Targeted Drugs Therapy
    Figure 6. Chemo Therapy
    Figure 7. Adjuvant Chemotherapy
    Figure 8. Radiation Therapy
    Figure 9. Global Gastrointestinal Cancer Treatment Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 10. Gastrointestinal Cancer Treatment Consumption Value Market Share by Application in 2023
    Figure 11. Hospitals Picture
    Figure 12. Clinics Picture
    Figure 13. Research Centers Picture
    Figure 14. Others Picture
    Figure 15. Global Gastrointestinal Cancer Treatment Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 16. Global Gastrointestinal Cancer Treatment Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 17. Global Market Gastrointestinal Cancer Treatment Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 18. Global Gastrointestinal Cancer Treatment Consumption Value Market Share by Region (2019-2030)
    Figure 19. Global Gastrointestinal Cancer Treatment Consumption Value Market Share by Region in 2023
    Figure 20. North America Gastrointestinal Cancer Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 21. Europe Gastrointestinal Cancer Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 22. Asia-Pacific Gastrointestinal Cancer Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 23. South America Gastrointestinal Cancer Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 24. Middle East and Africa Gastrointestinal Cancer Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 25. Global Gastrointestinal Cancer Treatment Revenue Share by Players in 2023
    Figure 26. Gastrointestinal Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 27. Global Top 3 Players Gastrointestinal Cancer Treatment Market Share in 2023
    Figure 28. Global Top 6 Players Gastrointestinal Cancer Treatment Market Share in 2023
    Figure 29. Global Gastrointestinal Cancer Treatment Consumption Value Share by Type (2019-2024)
    Figure 30. Global Gastrointestinal Cancer Treatment Market Share Forecast by Type (2025-2030)
    Figure 31. Global Gastrointestinal Cancer Treatment Consumption Value Share by Application (2019-2024)
    Figure 32. Global Gastrointestinal Cancer Treatment Market Share Forecast by Application (2025-2030)
    Figure 33. North America Gastrointestinal Cancer Treatment Consumption Value Market Share by Type (2019-2030)
    Figure 34. North America Gastrointestinal Cancer Treatment Consumption Value Market Share by Application (2019-2030)
    Figure 35. North America Gastrointestinal Cancer Treatment Consumption Value Market Share by Country (2019-2030)
    Figure 36. United States Gastrointestinal Cancer Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 37. Canada Gastrointestinal Cancer Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 38. Mexico Gastrointestinal Cancer Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 39. Europe Gastrointestinal Cancer Treatment Consumption Value Market Share by Type (2019-2030)
    Figure 40. Europe Gastrointestinal Cancer Treatment Consumption Value Market Share by Application (2019-2030)
    Figure 41. Europe Gastrointestinal Cancer Treatment Consumption Value Market Share by Country (2019-2030)
    Figure 42. Germany Gastrointestinal Cancer Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 43. France Gastrointestinal Cancer Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 44. United Kingdom Gastrointestinal Cancer Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 45. Russia Gastrointestinal Cancer Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 46. Italy Gastrointestinal Cancer Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 47. Asia-Pacific Gastrointestinal Cancer Treatment Consumption Value Market Share by Type (2019-2030)
    Figure 48. Asia-Pacific Gastrointestinal Cancer Treatment Consumption Value Market Share by Application (2019-2030)
    Figure 49. Asia-Pacific Gastrointestinal Cancer Treatment Consumption Value Market Share by Region (2019-2030)
    Figure 50. China Gastrointestinal Cancer Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 51. Japan Gastrointestinal Cancer Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 52. South Korea Gastrointestinal Cancer Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 53. India Gastrointestinal Cancer Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 54. Southeast Asia Gastrointestinal Cancer Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 55. Australia Gastrointestinal Cancer Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 56. South America Gastrointestinal Cancer Treatment Consumption Value Market Share by Type (2019-2030)
    Figure 57. South America Gastrointestinal Cancer Treatment Consumption Value Market Share by Application (2019-2030)
    Figure 58. South America Gastrointestinal Cancer Treatment Consumption Value Market Share by Country (2019-2030)
    Figure 59. Brazil Gastrointestinal Cancer Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 60. Argentina Gastrointestinal Cancer Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 61. Middle East and Africa Gastrointestinal Cancer Treatment Consumption Value Market Share by Type (2019-2030)
    Figure 62. Middle East and Africa Gastrointestinal Cancer Treatment Consumption Value Market Share by Application (2019-2030)
    Figure 63. Middle East and Africa Gastrointestinal Cancer Treatment Consumption Value Market Share by Country (2019-2030)
    Figure 64. Turkey Gastrointestinal Cancer Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 65. Saudi Arabia Gastrointestinal Cancer Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 66. UAE Gastrointestinal Cancer Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 67. Gastrointestinal Cancer Treatment Market Drivers
    Figure 68. Gastrointestinal Cancer Treatment Market Restraints
    Figure 69. Gastrointestinal Cancer Treatment Market Trends
    Figure 70. Porters Five Forces Analysis
    Figure 71. Manufacturing Cost Structure Analysis of Gastrointestinal Cancer Treatment in 2023
    Figure 72. Manufacturing Process Analysis of Gastrointestinal Cancer Treatment
    Figure 73. Gastrointestinal Cancer Treatment Industrial Chain
    Figure 74. Methodology
    Figure 75. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Eli Lilly
F. Hoffmann
GlaxoSmithKline
Merck
Novartis AG
Otsuka Holdings
Stryker Corporation
Boston Scientific Corporation
Johnson and Johnson
CONMED Corporation
Bristol-Myers Squibb
Pfizer
Celltrion Inc
Amgen Limited
Celgene Corporation
Sanofi
Mylan N.V.
Samsung Bioepis
Teva Pharmaceutical Industries Ltd.

Related Reports

Global Gastrointestinal Cancer Treatment Supply, Demand and Key Producers, 2023-2029

Global Gastrointestinal Cancer Treatment Supply, Demand and Key Producers, 2023-2029

date 08 Sep 2023

date Medical Care

The global Gastrointestinal Cancer Treatment market size is expected to reach $ 9137.4 million by 2029, rising at a market growth of 12.0% CAGR during the forecast period (2023-2029).

Global Gastrointestinal Cancer Treatment Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Gastrointestinal Cancer Treatment Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 08 Sep 2023

date Medical Care

According to our (Global Info Research) latest study, the global Gastrointestinal Cancer Treatment market size was valued at USD 4128.1 million in 2022 and is forecast to a readjusted size of USD 9137.4 million by 2029 with a CAGR of 12.0% during review period.

Product Tags

Gastrointestinal Cancer Treatment

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>